abstract |
Disclosed is a stable pharmaceutical composition comprising one azetidine derivative N-{1-[bis(4-chlorophenyl)methyl]azetidin-3-yl}-N-(3,5-difluorophenyl)methyl sulphonamide in a system comprising: (i) phospholipid, or (ii) a combination of capylic/capric triglyceride, propylene glycol monocaprylate and a polyoxyl castor oil or polyoxyl hydrogenated castor oil. |